Vip Patel

Array ( [id] => 3767293 [patent_doc_number] => 05849523 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Aedes aegypti densovirus expression system' [patent_app_type] => 1 [patent_app_number] => 8/485341 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 10323 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849523.pdf [firstpage_image] =>[orig_patent_app_number] => 485341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3933200 [patent_doc_number] => 05972643 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Isolated polynucleotide molecules encoding CTCF, a CCCTC-binding factor' [patent_app_type] => 1 [patent_app_number] => 8/475844 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25877 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972643.pdf [firstpage_image] =>[orig_patent_app_number] => 475844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3660436 [patent_doc_number] => 05624820 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'Episomal expression vector for human gene therapy' [patent_app_type] => 1 [patent_app_number] => 8/479204 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13262 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/624/05624820.pdf [firstpage_image] =>[orig_patent_app_number] => 479204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3662816 [patent_doc_number] => 05599544 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-04 [patent_title] => 'Recombinant infectious bovine rhinotracheitis virus' [patent_app_type] => 1 [patent_app_number] => 8/479650 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 48 [patent_no_of_words] => 28943 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/599/05599544.pdf [firstpage_image] =>[orig_patent_app_number] => 479650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3834346 [patent_doc_number] => 05846714 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Method of identifying a chemical that alters dissociation of an NF-KB/IKB complex' [patent_app_type] => 1 [patent_app_number] => 8/475359 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 12448 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846714.pdf [firstpage_image] =>[orig_patent_app_number] => 475359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3777770 [patent_doc_number] => 05820871 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-13 [patent_title] => 'Recombinant negative strand RNA virus expression systems and vaccines' [patent_app_type] => 1 [patent_app_number] => 8/470887 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 42 [patent_no_of_words] => 33413 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/820/05820871.pdf [firstpage_image] =>[orig_patent_app_number] => 470887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3623702 [patent_doc_number] => 05607918 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-04 [patent_title] => 'Vascular endothelial growth factor-B and DNA coding therefor' [patent_app_type] => 1 [patent_app_number] => 8/469427 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 6800 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/607/05607918.pdf [firstpage_image] =>[orig_patent_app_number] => 469427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3704002 [patent_doc_number] => 05654137 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Human CRABP-I and CRABP-II' [patent_app_type] => 1 [patent_app_number] => 8/468709 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 14067 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/654/05654137.pdf [firstpage_image] =>[orig_patent_app_number] => 468709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3804061 [patent_doc_number] => 05830756 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'DNA and expression vector encoding I.kappa.B Protein' [patent_app_type] => 1 [patent_app_number] => 8/466337 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 12397 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830756.pdf [firstpage_image] =>[orig_patent_app_number] => 466337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3925144 [patent_doc_number] => 05877004 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Human cytomegalovirus containing a .beta.-glucuronidase marker gene' [patent_app_type] => 1 [patent_app_number] => 8/462334 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 66 [patent_no_of_words] => 20974 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/877/05877004.pdf [firstpage_image] =>[orig_patent_app_number] => 462334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3803331 [patent_doc_number] => 05830707 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Method for site-specific integration of nucleic acids and related products' [patent_app_type] => 1 [patent_app_number] => 8/464257 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 13074 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830707.pdf [firstpage_image] =>[orig_patent_app_number] => 464257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1338477 [patent_doc_number] => 06589733 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-08 [patent_title] => 'Methods of preparing compositions comprising chemicals capable of transcriptional modulators' [patent_app_type] => B1 [patent_app_number] => 08/463398 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 14488 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 194 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/589/06589733.pdf [firstpage_image] =>[orig_patent_app_number] => 08463398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3683031 [patent_doc_number] => 05690937 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-25 [patent_title] => 'Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene' [patent_app_type] => 1 [patent_app_number] => 8/462388 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11757 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/690/05690937.pdf [firstpage_image] =>[orig_patent_app_number] => 462388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3754353 [patent_doc_number] => 05720957 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-24 [patent_title] => 'Recombinant human cytomegalovirus vaccine' [patent_app_type] => 1 [patent_app_number] => 8/459586 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 39 [patent_no_of_words] => 11338 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/720/05720957.pdf [firstpage_image] =>[orig_patent_app_number] => 459586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3738136 [patent_doc_number] => 05753476 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Identification of a human cytomegalovirus gene region involved in down regulation of MHC class I heavy chain expression' [patent_app_type] => 1 [patent_app_number] => 8/458544 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 39 [patent_no_of_words] => 9361 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753476.pdf [firstpage_image] =>[orig_patent_app_number] => 458544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3741267 [patent_doc_number] => 05800986 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-01 [patent_title] => 'Assay methods for tat cell lines' [patent_app_type] => 1 [patent_app_number] => 8/456346 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 7638 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 204 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/800/05800986.pdf [firstpage_image] =>[orig_patent_app_number] => 456346 [rel_patent_id] =>[rel_patent_doc_number] =>)